Biotech News

Stryker declares an $0.88 per share quarterly dividend

Stryker (SYK)StrykerEarnings

Home Stock Information Stock Quote

Stock Chart

Historical Stock Quote

Analyst Coverage

Dividend History

Financial Information Quarterly Results

Annual Reports

SEC Filings

Proxy Materials

Governance Governance Documents

Executive Management

Board of D irectors

Press Releases

Events & Presentations

Investor Resources Investor Contacts

Investor Email alerts

INVESTOR INQUIRY/COMMENT

RSS Feeds

View all news

Stryker declares an $0.88 per share quarterly dividend

05/07/2026

Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com .

Contacts

For investor inquiries: Nick Mead, Vice President, Investor Relations at 269-385-2600 or nick.mead@stryker.com

For media inquiries: Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or kim.montagnino@stryker.com

Source: Stryker Corporation

Categories: Press Releases

View all news

Related news

Stryker

Global MedTech Leader Stryker is a global medical technology company offering products and services across MedSurg, Neurotechnology, and Orthopaedics. Its scale, global customer base, and product breadth make it one of the largest diversified medtech companies, with products that support surgical procedures, hospital workflows,...

Recent company news

Stock data

Close
337.43 USD
Market cap
112.44B USD
Exchange
NYSE
Sector
Biopharma
Location
United States